zhjmedical.com (ZJYL) Narxning foydaga nisbati

Jin Medical (ZJYL) korporativ emblemasi va logotipi

Ushbu grafikda aks etgan Jin Medical International (ZJYL) aktivlarining qiymati 489.90 miqdoridagi P/E koeffitsiyentini ko'rsatmoqda. Jin Medical International (ZJYL) yuqori texnologiyali nogironlar aravachalarini ishlab chiqish bo'yicha global yetakchi sifatida tan olingan bo'lib, ergonomika va qulaylik uchun foydalanuvchilarning e'tirofini qozongan. Biznes Xitoy va Yaponiyadagi kuchli pozitsiyalarga tayanib, keksalar uchun aqlli yengil qurilmalarni yaratadi. Rivojlanish reabilitatsiya mahsulotlari liniyasiga robototexnika va yangi materiallarning integratsiyasiga asoslangan.

Jin Medical International Ltd (ZJYL) Narx-foyda koeffitsiyenti: 11.05.2024 - 17.11.2026 davri uchun

Jin Medical (ZJYL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning umumiy tahlili:Jin Medical International Ltd. - ZJYL
zhjmedical.com original mahsuloti

Jin Medical International (ZJYL) uchun foyda ko'rsatkichi (P/E) reabilitatsiya uskunalarining haqiqiy ishlab chiqarish samaradorligi va spekulyativ optimizm o'rtasidagi filtr vazifasini o'taydi. P/E ko'rsatkichi tendentsiyasini tahlil qilish orqali investorlar geosiyosiy risklar va AQSh savdo to'siqlarini hisobga olgan holda kapitalning qoplanish muddatini baholaydilar, bunda ushbu metrikadagi og'ishlar biznesning qadriyatidan past baholanganligini yoki daromadlar barqarorligiga yashirin tizimli tahdidlar mavjudligini anglatadi.

Raqobatdosh kompaniyalar tahlili

Narxning foydaga nisbati BSX|Narx-foyda koeffitsiyenti EW (Edwards Lifesciences Corporation)|Biznesning o‘zini qoplash muddati ResMed Inc.|P/E multiplikatori PODD (insulet.com)|ZBH (Zimmer Biomet Holdings, Inc.) - Kapitalizatsiyaning sof foydaga nisbati|CooperSurgical - P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati ALGN|GMED: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati TransMedics Group (TMDX)|ATEC (Alphatec) - P/E multiplikatori|Narx-foyda multiplikatori AORT (Artivion)|Narx-foyda koeffitsiyenti ENOV (Enovis)|IART (Integra LifeSciences Corp) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Establishment Labs Inc ESTA|BBNX - Narx-foyda koeffitsiyenti|IRADIMED Corp - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Embecta Corp.|TNDM: P/E multiplikatori|Narx-foyda multiplikatori AXGN|SIBN (SI-BONE Medical) - P/E multiplikatori|Orthofix International (OFIX) - Biznesning o‘zini qoplash muddati|P/E multiplikatori BVS|Narx-foyda koeffitsiyenti OrthoPediatrics KIDS|P/E multiplikatori TMCI (treace.com)|P/E multiplikatori Blade Air Mobility SRTA|CARL - Narxning foydaga nisbati|RXST: Narxning foydaga nisbati|CLPT (ClearPoint) - Narx-foyda koeffitsiyenti|Stereotaxis, Inc. - Kompaniya qiymatining sof foydaga nisbati|STIM (Neuronetics, Inc) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Sight Sciences Inc. SGHT|Narxning foydaga nisbati orchestrabiomed.com (OBIO)|Anika (ANIK) - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|InspireMD Inc. - Narx-foyda koeffitsiyenti|P/E multiplikatori Vivani VANI|Xtant Medical Holdings, Inc. - P/E multiplikatori|Biznesning o‘zini qoplash muddati NeuroOne NMTC|Modular Medical, Inc. (MODD) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Myomo, Inc|Narxning foydaga nisbati envoymedical.com|Narx-foyda koeffitsiyenti Vivos Therapeutics (VVOS)|P/E multiplikatori NVNO|SINT - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Tenon Medical, Inc. TNON|LFWD: Narx-foyda multiplikatori|AMIX: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati invobioscience.com IVF|BBLG: P/E multiplikatori|Axonics Modulation Technologies (AXNX) - P/E multiplikatori|BIOL (Biolase Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati dynatronics.com DYNT|P/E multiplikatori FNA|Narxning foydaga nisbati INVO (INVO Bioscience Inc.)